AOC3 and hearing loss disorder: Like safinamide, the non-propargylamine LJP-1207 did not influence kanamycin-induced hearing impairment (AGIHL) even though it has anti-inflammatory effects [107] and as an SSAO/VAP1 inhibitor, it could alleviate oxidative stress and neuronal damage, as well [47, 49, 50].